Inflamaging: Where Biology Meets Visible Aging

Dr Dima Maraqa

MD

Dr. Dima Maraqa is a dentist and aesthetic practitioner based in Amman, Jordan, specializing in non-surgical facial aesthetics since 2016. She has a strong passion for the science and technology behind every procedure she performs. She believes that true beauty starts with knowledge, precision, and evidence-based techniques. Her approach focuses on achieving natural, safe, and long-lasting results for every patient.

https://www.instagram.com/dimamaraqa

Introduction

Inflamaging — a term combining inflammation and aging — describes a chronic, low‑grade inflammatory state that develops progressively with age. Unlike acute inflammation, which is protective and self‑limited, inflamaging is silent, persistent, and cumulative. It is driven by cellular senescence, immune dysregulation, oxidative stress, and mitochondrial dysfunction. Over time, this inflammatory milieu accelerates tissue degeneration internally and manifests externally through visible skin aging. Understanding inflamaging allows aesthetic practitioners to address aging at its biological roots rather than treating surface changes alone.

Cellular and Molecular Pathways of Inflamaging

At the cellular level, aging tissues accumulate senescent cells that no longer divide but remain metabolically active. These cells secrete pro‑inflammatory mediators collectively known as the senescence‑associated secretory phenotype (SASP), including interleukin‑6 (IL‑6), interleukin‑1β (IL‑1β), tumor necrosis factor‑α (TNF‑α), and matrix metalloproteinases (MMPs). These mediators degrade extracellular matrix components, disrupt fibroblast function, and impair tissue regeneration.

Mitochondrial dysfunction further amplifies inflamaging by increasing reactive oxygen species (ROS) production. Excess ROS activates nuclear factor‑κB (NF‑κB) and inflammasome pathways, perpetuating inflammatory signaling. In parallel, immunosenescence reduces the efficiency of immune clearance, allowing senescent cells and inflammatory mediators to persist. This self‑sustaining cycle links molecular aging processes directly to structural tissue decline.

How Inflamaging Affects Skin Structure and Appearance

The skin is particularly vulnerable to inflamaging due to its constant exposure to environmental stressors. Chronic inflammation disrupts collagen synthesis, accelerates elastin fragmentation, and alters glycosaminoglycan content, including hyaluronic acid. Dermal thinning, reduced hydration, and impaired barrier function follow.

Clinically, inflamaging manifests initially as subtle changes: fine lines, uneven texture, dullness, and early dyschromia. Over time, these changes progress to deeper wrinkles, laxity, and compromised regenerative capacity. Importantly, these visible signs often appear before overt systemic disease, positioning the skin as an early marker of biological aging.

Early Clinical Signs of Inflamaging (Educational Images)

Early fine lines around the periorbital area

Figure 1. Clinical close‑up showing early fine lines around the periorbital region, representing early structural and inflammatory skin aging. Image courtesy of Dima Maraqa Clinic, Amman, Jordan. Published with patient consent

Perioral fine lines / early texture change

Figure 2. Early perioral fine lines and textural changes associated with chronic low‑grade inflammation and dermal matrix degradation. Image courtesy of Dima Maraqa Clinic, Amman, Jordan. Published with patient consent.

These early signs reflect underlying inflammatory activity rather than chronological age alone and highlight the importance of early intervention.

Clinical Relevance for Aesthetic Practice

From an aesthetic perspective, inflamaging explains why some patients demonstrate accelerated aging despite minimal sun exposure or healthy lifestyles. Chronic inflammation alters tissue quality, reducing the effectiveness and longevity of aesthetic treatments if not addressed holistically.

Hyaluronic acid (HA) fillers not only restore volume but also improve hydration and modulate inflammatory signaling. Biostimulatory agents such as poly‑L‑lactic acid (PLLA) promote collagen neogenesis and improve dermal resilience over time. However, optimal outcomes require addressing the inflammatory environment through skin barrier repair, antioxidant support, and patient‑specific treatment planning.

Prevention and Modulation of Inflamaging

Preventive strategies should target both intrinsic and extrinsic drivers of inflammation. These include:

• Photoprotection to reduce UV‑induced inflammatory signaling
• Antioxidant‑rich skincare and nutrition
• Barrier‑supportive topical formulations
• Adequate sleep, stress management, and metabolic health optimization

Early, consistent interventions can slow the progression of inflamaging and improve long‑term aesthetic outcomes.

Clinical Takeaway for Practitioners

• Inflamaging is a biological process that precedes visible aging
• Early skin changes often reflect underlying chronic inflammation
• Aesthetic treatments should combine structural correction with inflammatory modulation
• Patient education is essential for long‑term success

By integrating biological understanding with clinical observation, practitioners can deliver more effective, natural, and sustainable aesthetic outcomes.

References

1. Franceschi C, Campisi J. Chronic inflammation (Inflammaging) and its potential contribution to age‑associated diseases. J Gorontalo A Biol Sci Med Sci. 2014;69 Suppl 1:S4‑9.
2. López‑Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194‑217.
3. Furman D, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822‑32.
4. Quan T, Fisher GJ. Role of age‑associated alterations of the dermal extracellular matrix microenvironment in human skin aging. Gerontology. 2015;61(5):427‑34.
5. Passi A, et al. Hyaluronan and inflammation. Int J Cell Biol. 2011;2011:1‑12.

More By This Author

• Where Biology Meets Visible Aging: Understanding and Managing Inflamaging
• Botulinum Toxin Resistance: Why It Happens and How We Can Handle It